Literature DB >> 36267216

FRAGILITY FRACTURES OF THE SACRUM: A SILENT EPIDEMIC.

Stefano Cattaneo1, Marco Adriani2, Stefano Tonolini2, Michel Oransky1, Claudio Galante1, Giuseppe Grava1, Giuseppe Milano3, Alessandro Casiraghi1.   

Abstract

Fragility fractures of the sacrum (FFS) are caused by low-energy trauma in the elderly population. Due to the nuanced symptomatology, many FFS remains unrecognized and the prevalence is underestimated. The clinical presentation varies, typically presenting with weightbearing low back pain without even remembering of a previous trauma. Radiographs are usually insufficient for the diagnosis and second level imaging modalities are required. In particular, magnetic resonance demonstrated the highest diagnostic accuracy. Treatment should aim to guarantee early mobilization and weightbearing, efficient pain relief and early discharge from the hospital to a proper facility for rehabilitation. Conservative treatment is reserved to non-displaced fractures with an adequate pain relief within one week allowing early mobilization. Otherwise, surgical treatment must be preferred. Nowadays, minimally invasive techniques, such as ileo-sacral screws or trans-sacral bar osteosynthesis, are safe and effective procedures and have overcome open procedures. In more complex patterns, with complete dissociation between the pelvic ring and the ilio-lumbar spine, spino-pelvic fixation is the procedure of choice.

Entities:  

Keywords:  Fragility fracture; Osteoporosis; Pelvis; Sacrum; Treatment

Year:  2022        PMID: 36267216      PMCID: PMC9568418          DOI: 10.52965/001c.38572

Source DB:  PubMed          Journal:  Orthop Rev (Pavia)        ISSN: 2035-8164


  57 in total

1.  Fragility fractures of the pelvis.

Authors:  Gillian L S Soles; Tania A Ferguson
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

2.  Implementation of a standardized protocol to manage elderly patients with low energy pelvic fractures: can service improvement be expected?

Authors:  Nikolaos K Kanakaris; Tess Greven; Robert M West; Arie B Van Vugt; Peter V Giannoudis
Journal:  Int Orthop       Date:  2017-07-21       Impact factor: 3.075

3.  Sacral fractures: an important problem. Retrospective analysis of 236 cases.

Authors:  F Denis; S Davis; T Comfort
Journal:  Clin Orthop Relat Res       Date:  1988-02       Impact factor: 4.176

4.  Pelvic insufficiency fractures in patients with pelvic irradiation.

Authors:  A Moreno; J Clemente; C Crespo; A Martínez; M Navarro; L Fernández; J Minguell; G Vázquez; F J Andreu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

Review 5.  Sacral insufficiency fractures: current concepts of management.

Authors:  E Tsiridis; N Upadhyay; P V Giannoudis
Journal:  Osteoporos Int       Date:  2006-07-20       Impact factor: 4.507

6.  Iliosacral screw fixation: early complications of the percutaneous technique.

Authors:  M L Routt; P T Simonian; W J Mills
Journal:  J Orthop Trauma       Date:  1997-11       Impact factor: 2.512

7.  Osteoporosis with vertebral fractures associated with pregnancy and lactation.

Authors:  S Di Gregorio; K Danilowicz; Z Rubin; C Mautalen
Journal:  Nutrition       Date:  2000 Nov-Dec       Impact factor: 4.008

8.  Transverse fracture of the upper sacrum. Suicidal jumper's fracture.

Authors:  R Roy-Camille; G Saillant; G Gagna; C Mazel
Journal:  Spine (Phila Pa 1976)       Date:  1985-11       Impact factor: 3.468

9.  Efficacy and safety of percutaneous sacroplasty for painful osteoporotic sacral insufficiency fractures: a prospective, multicenter trial.

Authors:  Michael E Frey; Michael J DePalma; David X Cifu; Sarjoo M Bhagia; Jonathan S Daitch
Journal:  Spine (Phila Pa 1976)       Date:  2007-07-01       Impact factor: 3.468

Review 10.  Clinical pathways for fragility fractures of the pelvic ring: personal experience and review of the literature.

Authors:  Pol M Rommens; Christian Ossendorf; Philip Pairon; Sven-Oliver Dietz; Daniel Wagner; Alexander Hofmann
Journal:  J Orthop Sci       Date:  2014-10-17       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.